1-20 of 211 results for subject:Tuberculosis
Librarians' tools
- Search time
- 0.278 seconds
- Solr query time
- 0.005 seconds
- Search query
- subject:Tuberculosis
- We searched for
- subject_t:Tuberculosis OR subject_t:TB OR subject_ses:13401
Type
House
Session
More
Year
Department
Member
More
Primary member
More
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health what research her Department has commissioned into new anti-TB drugs; and when that research is expected to be concluded.
To ask the Secretary of State for Health what research her Department has commissioned into new anti-TB drugs; and when that research is expected to be concluded.
To ask the Secretary of State for Health (1) what the incidence of tuberculosis among people who entered the UK and became resident there within the previous five years was in (a) 1995, (b) 1998, (c) 2001, (d) 2004 and (e) the latest year for which figures are available;
To ask the Secretary of State for Health (1) what the incidence of tuberculosis among people who entered the UK and became resident there within the previous five years was in (a) 1995, (b) 1998, (c) 2001, (d) 2004 and (e) the latest year for which figures are available;
| Number and rate of non-UK born tuberculosis cases that entered the UK within the last five years (England) | ||
|---|---|---|
| Number | Rate per 100,000 population | |
| 1998 | 890 | 141.4 |
| 2001 | 1,311 | 156.2 |
| 2003 | 2,039 | 188.1 |
| Number and rate of UK-born tuberculosis cases (England) | ||
|---|---|---|
| Number | Rate per 100,000 population | |
| 1998 | 2,175 | 4.9 |
| 2001 | 1,963 | 4.4 |
| 2003 | 1,765 | 4.0 |
| Notes: | ||
| 1. No data is available for 1995 since this precedes the introduction of ETS and there was no National Tuberculosis Survey (these were carried out at five-yearly intervals prior to the introduction of ETS) in 1995. | ||
| 2. 2004 data are not available at present. | ||
| 3. The LFS population estimates which have been used to calculate rates are liable to sampling errors. | ||
| 4. ““Entry into the UK within the previous five years”” will include those who entered the UK during the year in which they were reported as a TB case e.g. for 1998 the data includes persons who entered the UK in 1998, 1997, 1996, 1995 and 1994. | ||
| Sources: | ||
| 1. Health Protection Agency Enhanced Tuberculosis Surveillance (ETS) system | ||
| 2. Data as at 24 October 2006 |
(2) what the rates of tuberculosis for population groups born in England was in (a) 1995, (b) 1998, (c) 2001, (d) 2004 and (e) the latest year for which figures are available.
(2) what the rates of tuberculosis for population groups born in England was in (a) 1995, (b) 1998, (c) 2001, (d) 2004 and (e) the latest year for which figures are available.
| Number and rate of non-UK born tuberculosis cases that entered the UK within the last five years (England) | ||
|---|---|---|
| Number | Rate per 100,000 population | |
| 1998 | 890 | 141.4 |
| 2001 | 1,311 | 156.2 |
| 2003 | 2,039 | 188.1 |
| Number and rate of UK-born tuberculosis cases (England) | ||
|---|---|---|
| Number | Rate per 100,000 population | |
| 1998 | 2,175 | 4.9 |
| 2001 | 1,963 | 4.4 |
| 2003 | 1,765 | 4.0 |
| Notes: | ||
| 1. No data is available for 1995 since this precedes the introduction of ETS and there was no National Tuberculosis Survey (these were carried out at five-yearly intervals prior to the introduction of ETS) in 1995. | ||
| 2. 2004 data are not available at present. | ||
| 3. The LFS population estimates which have been used to calculate rates are liable to sampling errors. | ||
| 4. ““Entry into the UK within the previous five years”” will include those who entered the UK during the year in which they were reported as a TB case e.g. for 1998 the data includes persons who entered the UK in 1998, 1997, 1996, 1995 and 1994. | ||
| Sources: | ||
| 1. Health Protection Agency Enhanced Tuberculosis Surveillance (ETS) system | ||
| 2. Data as at 24 October 2006 |
To ask the Secretary of State for International Development what funding he has made available to (a) the Global Fund and (b) other medical bodies for research into new vaccines for TB.
To ask the Secretary of State for International Development what funding he has made available to (a) the Global Fund and (b) other medical bodies for research into new vaccines for TB.
(2) if she will issue new guidance to the NHS on diagnosis and treatment of tuberculosis in response to the emergence of extreme drug-resistant tuberculosis.
(2) if she will issue new guidance to the NHS on diagnosis and treatment of tuberculosis in response to the emergence of extreme drug-resistant tuberculosis.
To ask the Secretary of State for Health (1) what plans are in place for rapid and accurate diagnosis and contact tracing for cases of extreme drug-resistant tuberculosis in the UK;
To ask the Secretary of State for Health (1) what plans are in place for rapid and accurate diagnosis and contact tracing for cases of extreme drug-resistant tuberculosis in the UK;
To ask the Secretary of State for Health if she will ensure rapid implementation of the National Institute for Health and Clinical Excellence guidelines on tuberculosis.
To ask the Secretary of State for Health if she will ensure rapid implementation of the National Institute for Health and Clinical Excellence guidelines on tuberculosis.
To ask the Secretary of State for Health which NHS trusts have not implemented the National Institute for Health and Clinical Excellence guidelines for the diagnosis of latent tuberculosis infection; and if she will make a statement.
To ask the Secretary of State for Health which NHS trusts have not implemented the National Institute for Health and Clinical Excellence guidelines for the diagnosis of latent tuberculosis infection; and if she will make a statement.
To ask the Secretary of State for Health what progress has been made towards establishing a national audit of treatment failures and deaths from tuberculosis.
To ask the Secretary of State for Health what progress has been made towards establishing a national audit of treatment failures and deaths from tuberculosis.
To ask the Secretary of State for Health what direct cost savings have been achieved through the ending of the Bacillus Calmette-Guerin vaccination programme in schools.
To ask the Secretary of State for Health what direct cost savings have been achieved through the ending of the Bacillus Calmette-Guerin vaccination programme in schools.
(2) what steps have been taken by her Department in response to the National Institute for Health and Clinical Excellence’s Guideline Development Group’s recommendations for a study to assess whether interferon gamma tests are more effective and acceptable than tuberculin skin tests; and if she will make a statement.
(2) what steps have been taken by her Department in response to the National Institute for Health and Clinical Excellence’s Guideline Development Group’s recommendations for a study to assess whether interferon gamma tests are more effective and acceptable than tuberculin skin tests; and if she will make a statement.
To ask the Secretary of State for Health (1) what assessment she has made of the reasons for the time taken to introduce interferon gamma tests for tuberculosis; and what assessment she has made of the potential impact of such an introduction on (a) NHS finances and (b) patient safety;
To ask the Secretary of State for Health (1) what assessment she has made of the reasons for the time taken to introduce interferon gamma tests for tuberculosis; and what assessment she has made of the potential impact of such an introduction on (a) NHS finances and (b) patient safety;
(4) if she will issue guidance to the NHS on the use of interferon gamma tests to diagnose latent tuberculosis in HIV/AIDS patients;
(4) if she will issue guidance to the NHS on the use of interferon gamma tests to diagnose latent tuberculosis in HIV/AIDS patients;
(2) if she will issue a reminder to NHS trusts that National Institute for Health and Clinical Excellence guidance recommends the use of interferon gamma tests for diagnosis of tuberculosis infection in immunocompromised patients;
(2) if she will issue a reminder to NHS trusts that National Institute for Health and Clinical Excellence guidance recommends the use of interferon gamma tests for diagnosis of tuberculosis infection in immunocompromised patients;
To ask the Secretary of State for Health when she will publish the tuberculosis research strategy.
To ask the Secretary of State for Health when she will publish the tuberculosis research strategy.
To ask the Secretary of State for Health (1) whether the National Institute for Health and Clinical Excellence programme to identify ineffective treatments being used by the NHS will examine the Mantoux skin test for tuberculosis;
To ask the Secretary of State for Health (1) whether the National Institute for Health and Clinical Excellence programme to identify ineffective treatments being used by the NHS will examine the Mantoux skin test for tuberculosis;
(5) what guidance and support she has offered to NHS trusts on implementation of National Institute for Health and Clinical Excellence guidelines on diagnosis of tuberculosis.
(5) what guidance and support she has offered to NHS trusts on implementation of National Institute for Health and Clinical Excellence guidelines on diagnosis of tuberculosis.
(3) what assessment she has made of compliance with National Institute for Health and Clinical Excellence clinical guidelines on diagnosis of tuberculosis;
(3) what assessment she has made of compliance with National Institute for Health and Clinical Excellence clinical guidelines on diagnosis of tuberculosis;
To ask the Secretary of State for Health what assessment she has made of progress towards the Chief Medical Officer's targets of (a) a two per cent. reduction per year in rates of tuberculosis in population groups born in England and (b) a reduction in the incidence of tuberculosis among...
To ask the Secretary of State for Health what assessment she has made of progress towards the Chief Medical Officer's targets of (a) a two per cent. reduction per year in rates of tuberculosis in population groups born in England and (b) a reduction in the incidence of tuberculosis among...
To ask the Secretary of State for Health what assessment she has made of implementation of the recommendations of the Chief Medical Officer's TB Action Plan.
To ask the Secretary of State for Health what assessment she has made of implementation of the recommendations of the Chief Medical Officer's TB Action Plan.